Target intelligence / Profile preview

Botrytis cinerea (B. cinerea)

Target
B. cinerea
Molecular classification
Fungus, Eukaryotic pathogen
01

Overview

Botrytis cinerea is a necrotrophic filamentous fungus that serves as a significant pathogen for over 1,400 plant species, causing the devastating disease known as gray mold. It is characterized by its ability to secrete a wide array of cell wall-degrading enzymes and reactive oxygen species (ROS) that trigger host cell death, allowing the fungus to feed on decomposing plant tissue [1, 2]. While it is primarily an agricultural concern affecting high-value crops like grapes, strawberries, and tomatoes, it also plays a dual role in viticulture by causing 'noble rot' under specific environmental conditions, which is essential for the production of certain dessert wines [3]. In human health, B. cinerea is recognized as a potent allergen and is the causative agent of 'winegrower's lung,' a form of hypersensitivity pneumonitis triggered by the inhalation of high concentrations of fungal spores [4]. From a pharmacological perspective, B. cinerea is not a single molecular target but rather a target organism for various classes of fungicides. Current chemical management strategies target specific fungal proteins and pathways, such as the succinate dehydrogenase complex (SDHIs), MAP kinases, and sterol biosynthesis enzymes [2, 5]. However, the fungus is notorious for its high genetic plasticity and rapid development of multi-drug resistance (MDR), often mediated by the overexpression of efflux transporters or point mutations in target genes. This high resistance profile presents a significant challenge for long-term agricultural disease control and necessitates the development of novel anti-fungal strategies [5, 6].

Other names
Gray moldBotryotinia cinereaNoble rotBotrytis mold
02

Mechanism of action

Inhibition of mitochondrial respiration (SDHIs), disruption of osmotic signal transduction, inhibition of methionine biosynthesis, inhibition of sterol biosynthesis (C-3 demethylase), and interference with microtubule assembly.

03

Biological functions

Necrotrophic pathogenesisCell wall degradationToxin productionSclerotia formationConidiation
04

Disease associations

Gray mold diseaseWinegrower's lung (Hypersensitivity pneumonitis)Allergic rhinitisAsthma
05

Safety considerations

Multi-drug resistance (MDR)Environmental toxicity of fungicidesCross-resistance between chemical classesPersistence of sclerotia in soil
06

Interacting drugs

Boscalid

7 more in the full profile.

07

Biomarkers

Botrytis-specific antigensPolygalacturonase activityB. cinerea DNA (via qPCR)Serum precipitins (in Winegrower's lung)

Beyond the preview

Go deeper on Botrytis cinerea (B. cinerea).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Botrytis cinerea (B. cinerea).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call